Skip to main content

and
  1. No Access

    Article

    A randomized, open-label study to compare two different dosing regimens of oral tranexamic acid in treatment of moderate to severe facial melasma

    Oral tranexamic acid (TXA) demonstrates promising results in melasma management. However, no clear consensus on the dosing and duration of maintenance doses of TXA therapy in melasma exists. In this study, we ...

    Rajsmita Bhattacharjee, Vinod Hanumanthu in Archives of Dermatological Research (2023)